• Home
  • Study Details
By physician referral or invitation only

UNCPM 22117 - Kaposi Sarcoma chemotherapy and research (KS-CARE)

The purpose of this study is to help us better understand how patients with KS will respond to treatment with chemotherapy. We know from previous research studies that even though chemotherapy cannot cure KS, it can help a lot to improve symptoms caused by KS and cause KS lesions to become less or even go away for long periods of time.

Age & Gender

  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive

Contact the Team

Location

Thank you for your interest, but this study is recruiting by invitation only.

International (South Africa)

Additional Study Information

Principal Investigator

Dirk Dittmer
Microbiology and Immunology

Study Type

Clinical or Medical
Observational

Study Topics

Cancer (Sarcoma (bone and soft tissue))
HIV/AIDS

IRB Number

21-2368

Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research